课题基金 / 基金详情

Variant antigen profiling: a novel genomic tool for diagnosis and surveillance of animal African trypanosomiasis.

Variant antigen profiling: a novel genomic tool for diagnosis and surveillance of animal African trypanosomiasis.
变异抗原分析:一种用于诊断和监测非洲动物锥虫病的新型基因组工具。
批准号:
BB/M022811/1
负责人:
Andrew Jackson
金额:
$59.28万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --

项目摘要

项目成果

Andrew Jackson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Animal African trypanosomiasis (AAT) is a livestock disease with frequent and devastating effects on animal health and on the development of sub-Saharan nations. This neglected tropical disease is caused by the parasite Trypanosoma congolense, which is spread by biting flies and infects the blood causing chronic anaemia, wastage and ultimately death if untreated. Unlike Human African trypanosomiasis ('sleeping sickness'), which is caused by a related parasite T. brucei, and is declining after successful intervention and much research, AAT remains very common and poorly known. Yet the annual costs of disease and treatment are estimated at ~$4.5 billion across 37 countries. The FAO considers AAT to "lie at the heart of Africa's struggle against poverty", and central to its Millennium Goals. Most research on African trypanosomes is directed at the model organism T. brucei, but given the profound effects of AAT on animals and people, we need research dedicated to the veterinary parasites to determine how parasite variation affects the course and severity of disease.All African trypanosomes use antigenic variation to avoid the immune response of their host. This involves the replacement of the protein coat covering the parasite surface each time the host produces antibodies to the protein. The protein is called the Variant Surface Glycoprotein (VSG) and is crucial to parasite survival and the severity of disease, determining the length of infection and resistance to innate host defences. The genomes of both T. brucei and T. congolense contain hundreds of VSG genes, of which just one is expressed at a time from a specific expression site. Together, this repertoire of alternative VSG genes is a ubiquitous, but highly variable, feature of trypanosome genomes that constantly changes in response to host immunity. We can use this repertoire to understand how parasites change through space and time, and what effect this has on disease. This project aims to measure variation in VSG repertoire across the T. congolense population, and then produce a novel tool for rapidly predicting the properties of a strain based on its VSG repertoire.I will produce genome sequences for 40 isolates sampled from T. congolense infections of cows. Until now, analysis of VSG repertoires on a population scale has been avoided because their complexity makes it impossible to use standard tools. Previously, I discovered that T. congolense VSG are divided into distinct types, each defined by unique protein motifs. I will quantify the VSG repertoire in each T. congolense isolate by comparing its VSG to these protein motifs. The relative abundance of the VSG types will produce a 'variant antigen profile' (VAP) for each isolate. To give the VAP some predictive power, I will identify which VSG are actually used in antigenic variation, (and those that might perform some other role), by identifying the active VSG gene present in the specific expression site and expressed on the parasite cell surface. I will also identify significant correlations of VAPs with geography, time, disease severity and parasite relatedness. A tool to generate and interpret a VAP will be accessible online, making it possible to predict the properties of any T. congolense isolate from genome sequence data using variant antigen profiling.AAT represents an enormous challenge to animal health and economic development in Africa and yet we have no detailed knowledge of how T. congolense varies and how this relates to the kind of disease we see. Such information would improve diagnosis, the efficiency of drug therapy and control measures, lead to earlier and more appropriate treatment for sick animals, and perhaps even identify proteins that could serve as vaccine targets. The time is right to develop a fast and simple approach to making sense of VSG diversity that can unlock the potential of trypanosome genomics for understanding AAT, estimating its risk and mitigating its effects.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.21203/rs.3.rs-1292471/v1
发表时间: 2022
期刊:
影响因子: --
作者: [Pereira S]
通讯作者: Pereira S
MOESM8 of Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7)
MOESM8 间日疟原虫候选疫苗的临床表达和抗原谱:裂殖子表面蛋白 7 (PvMSP-7)
DOI: 10.6084/m9.figshare.8275583
发表时间: 2019
期刊:
影响因子: --
作者: [Chew Cheng]
通讯作者: Chew Cheng
MOESM5 of Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7)
间日疟原虫候选疫苗的临床表达和抗原谱的 MOESM5:裂殖子表面蛋白 7 (PvMSP-7)
DOI: 10.6084/m9.figshare.8275562
发表时间: 2019
期刊:
影响因子: --
作者: [Chew Cheng]
通讯作者: Chew Cheng
DOI: 10.1093/gbe/evy186
发表时间: 2018-09-01
期刊: Genome biology and evolution
影响因子: 3.3
作者: [Abbas AH, Silva Pereira S, D'Archivio S, Wickstead B, Morrison LJ, Hall N, Hertz-Fowler C, Darby AC, Jackson AP]
通讯作者: Jackson AP
9
    Mechanisms for Microcephaly, Cancer and Autoinflammation
    • 批准号:
      MC_UU_00035/10
    • 项目类别:
      Intramural
    • 资助金额:
      $551.22万
    • 财政年份:
      2023
    • 负责人:
      Andrew Jackson
    • 依托单位:
    Closed-loop Neural Interface Technologies (Close-NIT) Network Plus
    • 批准号:
      EP/W035081/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $140.95万
    • 财政年份:
      2022
    • 负责人:
      Andrew Jackson
    • 依托单位:
    Discovery Projects - Grant ID: DP210101354
    • 批准号:
      ARC : DP210101354
    • 项目类别:
      Discovery Projects
    • 资助金额:
      $22.39万
    • 财政年份:
      2021
    • 负责人:
      Andrew Jackson
    • 依托单位:
    From Microcephaly to Genome Stability,Inflammation and Growth Regulation
    • 批准号:
      MC_UU_00007/5
    • 项目类别:
      Intramural
    • 资助金额:
      $576.45万
    • 财政年份:
      2018
    • 负责人:
      Andrew Jackson
    • 依托单位:
    国内基金
    海外基金
    COSMC/Tn antigen/mTOR 轴调控胃癌细胞转移的分子机制 研究
    • 批准号:
      2024JJ9400
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      赵娟霞
    • 依托单位:
    T细胞识别的鳞状细胞癌1型抗原增强干扰素-α抗丙型肝炎病毒作用的研究
    • 批准号:
      81170386
    • 项目类别:
      面上项目
    • 资助金额:
      45.0万元
    • 批准年份:
      2011
    • 负责人:
      赵鸿
    • 依托单位:
    新的膀胱癌特异基因UCA1在膀胱癌高表达的分子机理
    • 批准号:
      30801325
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2008
    • 负责人:
      张争
    • 依托单位:
    基于短寿蛋白肿瘤疫苗诱导的抗瘤作用及其机制的研究
    • 批准号:
      30771999
    • 项目类别:
      面上项目
    • 资助金额:
      33.0万元
    • 批准年份:
      2007
    • 负责人:
      王立新
    • 依托单位: